Comparative Pharmacokinetics and Safety of 3 Different Formulations of TNX-102 2.8 mg SL Tablets and Cyclobenzaprine 5 mg Oral Tablet in Healthy Adults
Condition: Healthy AdultsInterventions: Drug: TNX-102 SL Tablets at 2.8 mg; Drug: TNX-102-B SL Tablets at 2.8 mg; Drug: TNX-102-C SL Tablets at 2.8 mg; Drug: Cyclobenzaprine tabletsSponsor: Tonix Pharmaceuticals, Inc.Completed - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cyclobenzaprine | Research